Home › Research › Biomarkers
Performance of Alzheimer Disease Plasma Biomarkers in a Specialty Memory Clinic (S15.005)
Yoav D. Piura, Christian Lachner, Alicia Algeciras‐Schimnich, Daniel J. Figdore, Joshua A. Bornhorst, Neill R. Graff‐Radford, Gregory Scott Day. Neurology, 2025-04-07
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Evaluate the performance of emerging Alzheimer disease (AD) plasma biomarkers in a specialty memory clinic.
What this study adds
Evidence grade: Low
This entry only states the aim of evaluating how emerging Alzheimer's blood biomarkers perform in a specialty memory clinic. No results or conclusions are provided in the available text, so nothing can be said about what it means for treating, curing or preventing the disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Piura, Y. D., Lachner, C., Algeciras‐Schimnich, A., Figdore, D. J., Bornhorst, J. A., Graff‐Radford, N. R., et al. (2025). Performance of Alzheimer Disease Plasma Biomarkers in a Specialty Memory Clinic (S15.005). Neurology. https://doi.org/10.1212/wnl.0000000000210899
Vancouver
Piura YD, Lachner C, Algeciras‐Schimnich A, Figdore DJ, Bornhorst JA, Graff‐Radford NR, et al. Performance of Alzheimer Disease Plasma Biomarkers in a Specialty Memory Clinic (S15.005). Neurology. 2025. doi:10.1212/wnl.0000000000210899.
BibTeX
@article{piura2025-09e4dad9,
author = {Piura, Yoav D. and Lachner, Christian and Algeciras‐Schimnich, Alicia and Figdore, Daniel J. and Bornhorst, Joshua A. and Graff‐Radford, Neill R. and Day, Gregory Scott},
title = {{Performance of Alzheimer Disease Plasma Biomarkers in a Specialty Memory Clinic (S15.005)}},
journal = {Neurology},
year = {2025},
doi = {10.1212/wnl.0000000000210899},
url = {https://doi.org/10.1212/wnl.0000000000210899}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Evaluate the performance of emerging Alzheimer disease (AD) plasma biomarkers in a specialty memory clinic.
Why it matters
This entry only states the aim of evaluating how emerging Alzheimer's blood biomarkers perform in a specialty memory clinic. No results or conclusions are provided in the available text, so nothing can be said about what it means for treating, curing or preventing the disease.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Evidence strengthLow
How this study scored 34/100
Published in a leading specialty journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Neurology) |
| Journal's citation record | 4 / 4 | Neurology: journal h-index 525 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Gregory Scott Day: h-index 43 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Mayo Clinic: institution h-index 1,606 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 34 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.